Inflammatory Bowel Disease (IBD) is a complex, chronic condition that has become a significant concern in global healthcare. Affecting millions of people worldwide, IBD includes two primary forms: Ulcerative Colitis (UC) and Crohn's Disease (CD).

Atopic Dermatitis (AD) is a chronic inflammatory skin condition that affects millions of people worldwide. Characterized by intense itching, redness, and skin lesions, this disease poses significant challenges not only for those who suffer from it but also for researchers aiming to understand its co

Client case: Development of a Novel Antibody Drug Targeting IL-25 for Atopic Dermatitis(AD).Client: A pharmaceutical company developing a new antibody targeting the IL-25 pathway for the treatment of ADObjective: To establish the efficacy and safety of the new anti-IL-25 antibody in preclinical mode

Client No.1: Efficacy of Novel Compound in EAE Model Client Background:Our client is a pharmaceutical company that has developed a novel compound designed to target mitochondrial damage-related autophagy and possesses neuroregenerative properties. The client aims to explore the potential therapeutic